Article: Antimicrobial resistance profile of Pseudomonas aeruginosa producing metallo-[beta]-lactamases

Article: Quorum-sensing molecule 30-C-12-HSL has multiple virulence enhancing functions.
Drug Week;  June 27, 2003 ;     264 words ......cells and thus may alter the host response during P. aeruginosa infections, wrote R.S. Smith and colleagues. The researchers concluded...the bacteria and also on how the host responds to P. aeruginosa infections. Smith and colleagues published their study in Current...

Article: Data on endoscope reprocessors discussed by researchers at Kyushu University.(Report)
Biotech Week;  February 25, 2009 ;     446 words ......findings, 'An outbreak of Pseudomonas aeruginosa infections following thoracic surgeries occurring...Chemotherapy, An outbreak of Pseudomonas aeruginosa infections occurred after thoracic surgeries...Chemotherapy (An outbreak of Pseudomonas aeruginosa infections following thoracic ...

Article: TOBRAMYCIN.(Brief Article)
Chemical Market Reporter;  March 1, 1999 ;     43 words ...PathoGenesis Corporation, Seattle, Wash., has received marketing clearance from regulatory authorities in Canada and Argentina for Tobi (tobramycin solution for inhalation) for the management of cystic fibrosis patients with chronic pulmonary pseudomonas aeruginosa infections.

Article: Questions on causality and responsibility arising from an outbreak of Pseudomonas aeruginosa infections in Norway.(Analytic perspective)
Emerging Themes in Epidemiology;  October 23, 2008 ;     700+ words ......traced the source of a large outbreak of Pseudomonas aeruginosa infections to contaminated mouth swabs extensively used in Norwegian...norms. In this article, we will use the outbreak of P. aeruginosa infections to illustrate the relevance of various theories of causality...

Article: Profile gets first drug license for Promixin.
Pharma Marketletter;  March 3, 2003 ;     94 words ......indication also tackled by Chiron's TOBI (tobramycin), which was approved in the UK in 1999 specifically for Pseudomonas aeruginosa infections in CF. Profile says it will launch Promixin in the UK this month, with a European roll-out following mutual recognition...

Article: Pathogenesis Corp. Announces First International Approvals Of TOBI(R) (Tobramycin Solution for Inhalation).
PR Newswire;  February 16, 1999 ;     523 words ......fibrosis patients with chronic pulmonary Pseudomonas aeruginosa infections. Canada and Argentina represent the first markets for...antibiotic, in the U.S. for management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. In addition, PathoGenesis...

Article: FDA, CDC cite contaminated biopsy equipment.(Federal Drug Administration)(Centers for Disease Control and Prevention)
Family Practice News;  September 1, 2006 ;     640 words ......Disease Control and Prevention (CDC) described Pseudomonas aeruginosa infections in four patients who had undergone transrectal ultrasound-guid...likely source. The patients were hospitalized with P. aeruginosa infections within 6 days of having a biopsy at a clinic in Georgia...

Article: Researchers Identify Genetic Changes In Bacterial Biofilms.
Drug Week;  November 16, 2001 ;     700+ words ......individuals with biofilm infections, such as Pseudomonas aeruginosa infections in the lungs of individuals with cystic fibrosis. Using...to tobramycin, a frontline antibiotic used to treat P. aeruginosa infections. You get the idea that rpoS is a gene whose expression...

Article: Research on cystic fibrosis discussed by scientists at University of Liverpool.
Biotech Week;  January 28, 2009 ;     333 words ......quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.' According to a study from Liverpool, the United Kingdom...quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiology Letters, 2009;290(1):1-9). For additional...

Article: Data on bacteriology detailed by researchers at Technical University.
Life Science Weekly;  September 23, 2008 ;     417 words ......response may exacerbate underlying disease during P. aeruginosa infections, researchers in the United States report (see also Bacteriology...be employed as anti-inflammatory therapeutics for P. aeruginosa infections. Jahoor and colleagues published their study in the Journal...

Article: Reports outline Pseudomonas aeruginosa study findings from Humboldt University.(Report)
Health & Medicine Week;  May 26, 2008 ;     398 words ......study describes an outbreak of Pseudomonas aeruginosa infections caused by contaminated bottled still water...weekly basis to determine the number of P. aeruginosa infections and colonisations of ICU patients. Clinical...

Article: Pathogenesis Corp. Begins Patient Enrollment in TOBI Clinical Trial in The United Kingdom and Ireland.
PR Newswire;  April 15, 1999 ;     595 words ......inhalation with current practice in managing Pseudomonas aeruginosa infections in cystic fibrosis patients, said Professor Margaret...inhaled antibiotic, in the U.S. for management of P. aeruginosa infections in patients with cystic fibrosis. In addition, PathoGenesis...

Article: KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million.
Clinical Trials Week;  January 5, 2009 ;     679 words ......KaloBios is developing for the treatment of Pseudomonas aeruginosa infections. The antibody is currently in Phase 1/2 testing in both...trials in 2008: KB001 is an anti-infective for Pseudomonas aeruginosa infections being tested in cystic fibrosis and in intensive care...

Article: Corus Pharma Announces Positive Phase II Results for Cystic Fibrosis Drug; Corus 1020 Shows Impact On Pseudomonas Aeruginosa Infections.
PR Newswire;  October 15, 2004 ;     550 words ......infection as compared to intravenous administration. A Phase II study of 105 cystic fibrosis patients with Pseudomonas aeruginosa infections evaluated two dose groups (75 mg, 225 mg) taken twice daily for two weeks in a double blinded, placebo-controlled trial...